Papers

4

Total Citations

15

H-Index

2

About

Pamela Lu is a rising surgical researcher whose work focuses on advancing minimally invasive hepato-pancreato-biliary (HPB) surgery, with a particular emphasis on equitable access, cost-effectiveness, and oncologic outcomes. Her major contributions include identifying barriers to the adoption of minimally invasive HPB procedures and demonstrating that surgical approach can significantly impact early return to intended oncologic therapy after pancreatic cancer resection—a critical factor in improving patient survival. Lu has also conducted rigorous cost analyses comparing robotic versus open gastrectomy and pancreatectomy, providing essential data on the financial implications of implementing robotic surgery programs at cancer centers. Her 2024 paper on barriers to adoption has already garnered 7 citations, reflecting its timely relevance, while her 2025 cost analysis of robotic pancreatectomy implementation offers practical insights for hospital administrators and surgeons. Through her work, Lu is helping to shape a more evidence-based, equitable, and economically sustainable future for HPB surgical oncology.

Research Focus

Key Achievements

2
H-Index
4
Papers
15
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access
7 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 42
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago